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INFANT POPULATIONS AT RISK FOR POSSIBLE SHORT TERM AND LONG-
TERM CONSEQUENCES AFTER EXPOSURE TO PROLONGED SEDATION 
 
TIFFANIE LIU  
 
 
ABSTRACT 
Introduction: Prolonged sedation treatment in neonatal pediatric populations is 
associated with opioid and benzodiazepine tolerance, dependence, and 
withdrawal syndrome. Despite the clinical relevance of this problem, we have 
limited knowledge of the long-term repercussions. Current literature focuses on 
premature neonates and suggests that opioid exposure may cause 
neurodevelopmental sequelae. The main objective of this literature review was to 
investigate what infant populations are at risk of developing short-term and/or 
long-term consequences from prolonged infantile sedation exposure. 
 
Published Studies: A literature review was conducted on previous studies that 
focused primarily on the effects of opioids and benzodiazepines on infants and 
how it may affect the future development in these children. Studies show that 
short-term consequences include increased heart rate, increased respiratory 
rate, increased blood pressure, intracranial pressure fluctuations, and risk of 
further complications such as intraventriculat hemorrhage (IVH), periventricular 
  v
leukomalacia (PVL), or even death. Long-term repercussions incluse the 
possibility of decreased brain volume, decreased head circumference and body 
weight, intelligence deficits, and social and behavioral issues. 
 
Discussion: Standard pain and sedation management involves the use of opioids 
and benzodiazepines. Treatment duration and medication dosage depend on 
severity of the patient’s illness. Since prolonged sedation administration is often 
associated with tolerance and dependence, future research (such as long-term 
follow up of these infants at later neurological milestones) is necessary to 
determine possible short-term and long-term neurological and behavioural 
sequelae for infants exposed to prolonged treatment with opioids and 
benzodiazepines. Standardized pain and sedation management guidelines may 
also increase the effectiveness of treatment and drug administration. 
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INTRODUCTION 
 
Prolonged use of opioids and benzodiazepines is common practice for the pain 
and sedation management of the youngest of patients. This type of treatment is 
now considered our standard of care but prior to the 1990s, medications for pain 
were not administered to infants under the assumption that they could not feel 
any pain (Hall, 2007). Little was known about a newborn’s bodily responses to 
severe stress until Anand, Hansen, and Hickey conducted a study in 1990. Their 
study suggested that infants not only do feel pain, but they may have more 
extreme stress responses than adults when experiencing pain. To quantify stress 
responses, hormonal and metabolic stress markers were measured in the 
perioperative period of surgery for each individual infant (Anand et al., 1990). 
FIGURE 1 displays the measurement of the selected stress indicators during and 
up to 24 hours after surgery. Since the surgery was associated with a substantial 
increase in the chosen stress markers (plasma epinephrine, plasma 
norepinephrine, plasma insulin, and plasma glucagon), it indicated that infants do 
indeed feel pain (Anand et al., 1990). Furthermore, infants that died during the 
study had more extreme hormonal stress responses and more extreme 
metabolic responses (such as hyperglycemia, high lactate concentrations, high 
blood alanine concentrations, etc.) when compared to the infants that survived. 
From this information, it can be inferred that decreasing the levels of the stress 
indicators may improve the rate of survival. (Anand et al., 1990). 
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FIGURE 1: Hormonal changes (perioperative stress response) in neonates. Stress 
biomarkers for 15 infants with congenital heart diseases were measured. Data on plasma 
epinephrine, plasma norepinephrine, plasma insulin, and plasma glucagon were collected during 
the perioperative period and up to 24 hours afterwards. This data is compared to the preoperative 
baseline. Figure from Anand et al., 1990. 
 
 
Not only is there evidence that untreated pain is associated with detrimental 
perioperative stress (possibly leading to death), but untreated pain may also 
have direct consequences on the acute illness of the newborn, as well as current 
and future development of the newborn. (Bellu et al., 2010). Untreated pain may 
lead to short-term consequences such as fluctuation and instability of the heart 
rate, respiratory rate, intracranial pressure and oxygen saturation of the blood, 
 3 
blood pressure, and even lead to further complications (Anand, 1997). Pain may 
also disrupt ventilation and breathing patterns, therefore lessening the 
effectiveness of intubation (Bellu et al., 2010).  
 
So now that we know that infants, like older children and adults, do feel pain, 
more studies have been conducted, widening our scope of knowledge into the 
previously unknown world of neonatal pain. Infants and young adolescents 
actually have decreased pain thresholds and increased physiological responses 
to painful stimuli when compared to adults and older children (Craig, 1993). 
Chronic untreated pain may affect the developing infant’s brain and nervous 
system, resulting in long-term consequences (Anand et al, 1990). Sedation 
medications are thereby used to treat pain, in hopes of increasing comfort and 
preventing the effects of chronic untreated pain. Recommendations on a more 
aggressive approach to treating and preventing pain have actually been 
suggested (Bellu et al., 2010) but there are still uncertainties about the possible 
risk of long-term consequences from sedation medications (particularly opioids). 
 
Opioids such as fentanyl, hydromorphone, and morphine are administered to 
relieve pain in infants undergoing surgery or other painful procedures. Opioids 
are often used in combination with benzodiazepines such as diazepam, 
lorazepam, and midazolam for sedation of critically ill infants to reduce stress and 
agitation, especially during intubation and mechanical ventilation (Anand, 2001).  
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While these efforts have been proven to decrease stress and increase comfort 
for mechanically ventilated infants, such treatment is associated with high 
incidence of tolerance and dependence (Anand et al., 2010) and the possibility of 
acute and long-term sequelae is still widely unknown. 
 
Consequences of Untreated Pain 
In the last two decades, research and studies have revealed differences in pain 
processing between an infant’s developing brain and an adult brain. The nervous 
system of an infant is still developing and undergoing significant change. 
Research suggests that strong painful procedures or mild repeated procedures 
performed on infants may permanently modify their pain processing (Hatfield, 
2014). This may lead to long-term changes affecting the brain, 
neurodevelopment, pain modulation, and reactivity later in adulthood. 
Undermanaged acute pain in early childhood is considered to be the greatest risk 
factor for the development of chronic pain in children and adults (Hatfield, 2014). 
 
Undermanaged pain in neonates leads to both short-term and long-term 
consequences. Short-term consequences of painful procedures include 
decreased oxygen saturation, increased heart rate, fluctuation in intracranial 
pressure, and increased levels of epinephrine, norepinephrine, insulin, and 
glucagon (Bellu et al., 2010; Hatfield, 2014). Fluctuations in intracranial pressure 
and cerebral blood volume increase the risk of complications such as IVH 
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(Kaneyasu, 2012). Newborns may experience substantial pain as a result of 
acute or chronic illness, surgery, intubation, or intensive care treatment. These 
bouts of pain – treated or not - may result in tissue injury that may alter the 
development of pain pathways (Li, 2009). 
 
Injury or inflammation to the dorsal horn network in early life may contribute to 
altered development in spinal nociceptive processing. The neonatal brain and 
spinal cord are particularly vulnerable to stress and pain exposure since this is a 
crucial time for development and maturation. Noxious insults, surgical 
procedures, and repetitive pain or stress related exposures might permanently 
modify the development of the immature nervous system (Ranger, 2014).  It is 
hypothesized that long-term consequences may be linked to the plasticity of the 
neonate’s nervous system and altered neurodevelopment. This may mean that in 
adulthood, pain sensitivity may be altered; for example, increased sensitivity to 
pain in certain areas may remain and could result in hyperalgesia (Hatfield, 
2014). Studies in the preterm infant have shown that repeated pain or stress may 
cause long term consequences such as altered somatosensory processing 
(Abdulkader, 2008), pain sensitivity (Grunau, 2001), and response to pain 
(Grunau, 2005). For example, infants that required treatment in the NICU had an 
abnormally lowered threshold to tonic heat and mechanical touch when 
compared to controls (Abdulkader, 2008), which indicates an altered central 
sensitization (Ranger, 2014). Central sensitization in adulthood may lead to 
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prolonged states of chronic pain (Schwaller, 2014). These studies had findings of 
hypersensitivity, but hyposensitivity was also demonstrated in older children who 
had experienced a previous surgery and stay in the NICU as neonates (Walker, 
2009). Not only is the nervous system altered, but brain development may be as 
well. Increased exposure to painful or stressful procedures for preterm infants in 
the NICU was associated with reduced brain size, altered brain functional 
connectivity, and total brain injury (Inder et al., 2011). Alterations in 
neurobehaviour were also a result of infant stress exposure (Inder et al., 2011).  
 
Because of all the evidence pointing to short-term and long-term consequences 
of untreated or undermanaged pain, it is important for physicians and caretakers 
to adequately manage pain, particularly in newborns and infants. Adequately 
managing neonatal pain may be necessary for normal pain responses and 
neurological development (Anand et al., 1999). In the Neonatal Outcomes and 
Prolonged Analgesia in Neonates (NOPAIN) trial performed by Anand and 
colleagues (1999), benefits of analgesia and sedation for preterm neonates were 
demonstrated. The study suggested that morphine analgesia or midazolam 
sedation might improve neurologic outcomes for preterm neonates requiring 
mechanical ventilation when compared to no pain management. The results of 
this study are shown in FIGURE 2 (Anand et al., 1999).  
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FIGURE 2: Neurologic Outcomes. 67 preterm neonates that required ventilator support were 
separated into 3 groups receiving midazolam hydrochloride, morphine sulfate, or placebo. Poor 
neurological outcomes occurred in 24% of the placebo group, 4% of the morphine group, and 
32% of the midazolam group. Graph taken from Anand et al., 1999. 
 
The study indicates that the infants given morphine had a lower number of poor 
neurologic outcomes (such as IVH and periventricular leukomalacia, PVL) as 
opposed to the neonates receiving midazolam or placebo for treatment. These 
results suggest that preterm neonates on ventilator support who were 
administered a low-dose morphine infusion had reduced incidences of poor 
neurological outcomes (Anand et al., 1999). Due to the low sample size of the 
NOPAIN study, a future study would be necessary to confirm the results.  
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The NOPAIN pilot study led to a second study performed by Anand and his 
colleagues. The Neurologic Outcomes and Preemptive Analgesia in Neonates 
(NEOPAIN) trial was conducted to investigate the effect that preemptive 
administration of morphine could have on ventilated preterm infants. The 
morphine was found to decrease early neurologic injury, although it made no 
difference in the risk of severe IVH, periventricular leukomalacia, or death (Anand 
et al., 2004). Therefore, the use of opioids and benzodiazepines may not only 
prove to be beneficial in protecting the neonate’s neurological development, but 
may also help prevent short-term and long-term consequences of chronic 
untreated pain. 
 
Importance of Pain Management 
We now know that chronic untreated pain is detrimental to the developing 
neonate’s nervous system and neurological development. There are major 
benefits to using sedation to combat repeated stress or pain exposure in 
pediatric patients undergoing surgical procedures or mechanical ventilation, but 
are there adverse events (Grant, 2013) that could arise from prolonged sedation? 
Short-term consequences of prolonged opioid and benzodiazepine administration 
in infants such as tolerance, dependence, and withdrawal are known (Anand et 
al., 2010; van Dijk et al., 2007). But possible long-term sequelae from prolonged 
exposure to opioids and benzodiazepines are consequences that infants may 
also be at risk for. Children and adults in need of intubation are routinely 
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administered sedation medications. They have clear guidelines for the dosages 
of the medications necessary to treat the pain. But there is infinitely more 
variability in the approach to administering sedation medications to neonates. 
Since it was previously believed that infants did not fell any pain, this false notion 
may have accounted for the low usage of anesthetics for infants. According to 
Anand’s paper in 1997, opioids were being underutilized in neonatal intensive 
care units (NICUs). Infants are not able to verbally communicate their level of 
pain to their caretakers, resulting in the underestimation – or overestimation – of 
the medications necessary for adequate treatment.  
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PUBLISHED STUDIES 
 
 
Our knowledge of the long-term effects following postnatal opioid exposure is 
limited; research in premature neonates suggests that prolonged sedation 
exposure is associated with possible neurodevelopmental sequelae such as 
alterations in cerebral structure and possible neurobehavioral problems 
(Ferguson, 2012; McPherson et al., 2015). This literature review seeks to identify 
a population of infants with history of prolonged sedation associated with opioid 
and benzodiazepine dependence that are at risk for short-term consequences, 
also putting them at high risk for developing potential long-term sequelae.  
 
Current standard of care for infants undergoing painful procedures calls for 
administration of sedation medications. Opioids such as fentanyl and morphine 
and benzodiazepines such as lorazepam and midazolam are most often used for 
pain management. Pain management is supported by clinical evidence (Anand et 
al., 1999; Anand et al., 2004). However, much is still unknown about the 
repeated use or prolonged drug administration in the sedation of infants.  
 
Sedation Medications: Opioids and Benzodiazepines 
Opioids and benzodiazepines are commonly used together for sedation 
management. Opioids have long been known to produce tolerance and 
dependence when administered via continuous intravenous infusion. Morphine 
 11 
and fentanyl are used to manage pain differently. Morphine is a longer lasting 
drug, used for extended pain and sedation, such as chronic pain from surgical 
procedures (Silva, 2007). Fentanyl is a faster acting drug, more potent dose-for-
dose than morphine. In the case of intubation, fentanyl is often used since the 
long-acting (and therefore slow acting) morphine may cause a delay in 
sufficiently relaxing an infant’s airway at the time of laryngoscopy or intubation 
(Silva, 2007). Since fentanyl is faster acting, it also lasts for a shorter duration 
than morphine.  
 
Morphine and its effects have been more widely studied than fentanyl. Morphine 
has been widely used via continuous intravenous infusions for treating 
postoperative pain. In the cases of necessary intubation or mechanical 
ventilation, some studies have shown that morphine may no longer be the best 
choice (Kabara, 2015). Morphine causes respiratory depression, so for infants in 
requiring ventilator support, use of this drug could be detrimental. Fentanyl is 
faster acting in pain relief and sedation while also being superior to morphine 
when it comes to respiratory depression (Kabara, 2015), meaning it can be 
administered as a continuous infusion for postoperative pain instead of morphine.  
 
Opioids are known to induce tolerance and dependence particularly if used for 
prolonged durations. Prolonged sedation is defined as more than 72 hours of 
continuous sedation (Thornton and Smith, 1997) since drug tolerance rarely 
 12 
occurs before this point. Iatrogenic tolerance occurred when the given dose of a 
drug (in this case, morphine) was no longer effective and a larger dose became 
necessary to induce the same effects (analgesic level) as before (Thornton and 
Smith, 1997). Physical dependence could be seen when the drug use was 
discontinued and there were signs of withdrawal. Morphine studies in rats have 
shown that tolerance occurs after repeated or continuous exposure, although 
studies do not agree on the exact time tolerance occurs (Fanselow and Cramer, 
1988; Barr and Wang, 1992). In each of these studies, morphine was 
administered via bolus injection with different dosages and schedules, possibly 
accounting for the discrepancy. Another possible reason for their different results 
may have been due to the stress induced when handling and injecting the rat 
(Thornton and Smith, 1997). To remove these unwanted variances, Thornton and 
Smith (1997) used minipumps (as shown in Figure 3) to deliver the drug at a 
constant rate to the rats in order to test their hypothesis that continuous fentanyl 
administration could cause tolerance and dependence. 
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FIGURE 3: Osmotic Minipumps. Handling and manually injecting the neonatal rat with fentanyl 
causes stress, possibly creating variations in the results. The minipump implanted into infant rat 
for continuous infusion of fentanyl would reduce the unwanted handling stress and create a more 
cohesive and organized schedule for treatment of each rat. Photo taken from Thornton and 
Smith, 1997. 
 
While opioids are mostly used in the event of treating pain, benzodiazepines 
such as diazepam, lorazepam, and midazolam are used primarily for their 
sedative effects. Benzodiazepines are used to treat agitation as well as for 
withdrawal symptoms. For infants, opioids are used in combination with 
benzodiazepines for sedation management. Reports suggest that 
benzodiazepines used in high doses or extended durations may cause serious 
adverse effects (Ng, 2002; Uzun, 2010), although this has yet to be proven. 
 
Pain and Sedation Management 
Even the youngest of patients are treated with medications such as opioids and 
benzodiazepines for the management of pain and sedation. While there are clear 
guidelines for treating adults in intensive care units (ICU) (Figure 4), there is still 
great variability in the treatment of infants in the NICU.  
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FIGURE 4: Pain, agitation, and delirium (PAD) recommendations for adults in ICUs. Figure 
taken from Barr et al., 2013. 
. 
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The guidelines from Figure 4 give in depth directions for assessing and treating 
PAD in adults in the ICU. Not only are these guidelines given, but there is also a 
second set of instructions (Figure 5) for treatment (Barr et al., 2013), providing 
the physician or caretaker with a template for PAD care. These 
recommendations take into consideration not only how and what the patient is 
feeling, but also the ease of the physician to assess the patient and determine 
the best path of care. The goal of these guidelines is to optimize patient care and 
management in the ICU (Jacobi et al., 2002; Barr et al., 2013).  
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FIGURE 5: ICU PAD care bundle. A and B show easy to follow practice guidelines that are most 
likely to improve the patient’s outcome. Figure taken from Barr et al., 2013. 
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Self-reporting is a great asset in determining the treatment plan for pain in an 
adult in the ICU. But infants cannot self-report. This makes it much more difficult 
to determine how much pain the infant is in, since infants often cry but not always 
due to pain and agitation. The pain level directly influences the choice of 
medication and dose of medication necessary to adequately treat the pain. A 
study conducted by Martha Curley (who is widely known for her research and 
work related to the clinical management of critically ill infants) in 2006 developed 
and tested the State Behavioral Scale’s (SBS) reliability in describing agitation 
and sedation levels in infants requiring ventilator support. The SBS (Figure 6) 
was designed to help physicians evaluate what sedation level is necessary and 
appropriate for the infant undergoing a painful procedure (Curley, 2006). While 
we have mostly overcome the issue of undermanaged pain, the risk of over-
sedation still poses a problem. Since patients in the NICU are particularly 
vulnerable, the SBS has been used to help nurses and physicians to quickly and 
accurately assess and treat their young patients. 
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FIGURE 6: State Behavioral Scale (SBS). Behavioral assessment tool and rating scale for 
agitation. Figure taken from Curley, 2006. 
 
Using a standardized protocol for pain and sedation management may help to 
lower the incidence of under- or over-estimating necessary pain treatment for 
infants. Protocolized sedation has been proven to improve the clinical outcome 
for critically ill adults (Curley, 2015), but it has yet to be proven for infants. 
 20 
Because a team of caretakers is in charge of pain and sedation management in 
intensive care, doctors, nurses, and even pharmacists must work together to 
provide the best treatment (Curley, 2015). A widely used protocol could be put in 
place, providing less deviation in medication choice and dosage, allowing for a 
less varied outcome.  
 
Short-Term and Long-Term Consequences 
So far, much of the literature on the short-term and long-term effects of 
prolonged sedation with opioids and benzodiazepines is focused on premature 
neonates. Preterm infants in neonatal intensive care units (NICUs) often 
repeatedly experience painful procedures. Several studies have started to 
question and test the efficacy of sedative treatment.  
 
Short-term consequences, as opposed to long-term sequelae, have been better 
studied. The effects (tolerance, dependence, and withdrawal) of prolonged opioid 
and benzodiazepine use can be seen before the infant is discharged from the 
hospital. Some of these adverse effects may be unavoidable, but at some point 
the risks of pain and sedation treatment may outweigh the benefits. Maybe the 
possibility of withdrawal could be lessened or altogether avoid by reducing the 
amount of sedation medications administered to an infant.  
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In order to monitor withdrawal syndrome in infants and children, withdrawal 
assessment tool-1 (WAT-1) can be used. Withdrawal syndrome occurs when a 
critically ill patient that has received prolonged sedation is either suddenly 
removed from or too rapidly weaned off the drug (Curley et al., 2012). Length of 
time and total opioid and benzodiazepine exposure influence the severity and 
rate of weaning. Over 50% of patients in the pediatric intensive care unit (PICU) 
suffer from iatrogenic withdrawal after 5 days of continuous drug infusion (Curley, 
2013). Since iatrogenic withdrawal is a common, clinically significant side effect 
of prolonged sedation exposure, having a tool to assess the signs and symptoms 
for infants can greatly increase the clinical outcomes for these critically ill 
patients. The study showed that nurses were able to efficiently define and treat 
neonatal pain by using the WAT-1 (Curley et al., 2012), as shown in Figure 7.  
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FIGURE 7: Withdrawal Assessment Tool (WAT-1). Tool designed to be used twice a day to 
assess infant patient withdrawal. This rapid assessment can be easily used to provide decent 
accuracy, as opposed to other lengthier assessments. Figure taken from Curley et al., 2012. 
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Along with iatrogenic withdrawal, other sedation-related adverse effects may 
occur for infants in intensive care units. As always, there is the risk of 
undermanaging pain and sedation. Unplanned extubation or extubation failure 
were often experienced by younger patients, resulting in a longer hospital stay 
and an increased length of mechanical ventilation (Grant, 2013). In Grant’s study 
of sedation-related adverse effects (2013), adverse effects varied with the use of 
different sedation protocols. There is not currently a standardized treatment plan 
for pain and sedation management of critically ill infants. Many hospitals supply 
their physicians with their own recommended guidelines, making it difficult to 
compare protocols and determine which one is most effective. An example of 
sedation management guidelines is illustrated in Figure 8. Since these are 
recommendations, the team of physicians overseeing the critically ill patient 
ultimately designs the overall pain and sedation management, leading to 
variability in treatment in clinical outcome. 
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FIGURE 8: Boston Children’s Hospital Perioperative Pain Management Document From 
Patient Care Manual. These are the recommended guidelines for postoperative pain 
management - continuous infusions of opioids and benzodiazepines are suggested for prolonged 
sedation.  
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Undermanaging pain in infants is detrimental to the developing brain and nervous 
system, so pain and sedation management has the benefit of reducing the 
effects of chronic pain. The NEOPAIN trials (Anand, 2004) hypothesized that 
preemptive morphine would actually improve neurological outcomes in preterm 
neonates requiring mechanical ventilation. Although the study did not prove that 
pre-emptive morphine could decrease the occurrence of IVH, PVL, or death, the 
results did suggest that administering boluses of morphine were associated with 
a higher frequency of a positive outcome (Anand, 2004). These infants were not 
assessed after being discharged from the NICU, so long-term consequences 
were not able to be determined. The study conducted by de Graaf (2011) tested 
5 year olds that had previously required mechanical ventilation as neonates and 
as infants were part of the trial on effects of morphine administration on pain and 
neurologic outcome. The children were tested on intelligence, behavior, hand-
eye coordination, and health-related quality of life (de Graff et al., 2011). The 
results showed that short-term (5-7 days) morphine administration to preterm 
infants did not alter IQ, motor development, or behavioral problems at the age of 
5. But in the IQ subtest for “visual analysis” there was a significant effect of 
morphine - children who had received morphine for their first 28 days obtained 
“visual analysis” low scores (de Graaf et al., 2011). This finding warrants a need 
for a future study or follow-up to test for alterations in neurocognitive functions. In 
a newer study performed by Ferguson (2012), preemptive analgesia in preterm 
neonates “did not have significant effects on IQ, academic achievement, self-
 26 
sufficiency, or motivational assessments at 5-7 years of age,” echoing the results 
of de Graaf’s study. But Ferguson did find that head circumference and body 
weight were found to be decreased in the group of infants treated with morphine 
when compared to the control group (Ferguson, 2012). Figure 9 displays the 
results of head circumference and body weight of the subjects in each treatment 
group, treated with either a placebo or morphine. 
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FIGURE 9: Head circumference and body weight results for each treatment group. Graph A 
shows the measurements of head circumference and graph B shows the body weight results. 
Circles indicate male subject and triangles indicate female subject. Figure from Ferguson, 2012. 
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Using parent-reported scores on behavior-rating scales, it was also apparent that 
the morphine treated group suffered more social problems, had decision 
response latencies when performing short-term memory tasks, and experienced 
differences in social interactions, suggesting long-term consequences (Ferguson, 
2012). Although multiple study findings (de Graaf et al., 2011; Macgregor, 1998; 
Ferguson, 2012) have suggested that pre-emptive morphine administered to 
infants (particularly pre-term infants) does not lead to significant IQ deficits, the 
results of Ferguson’s study – decreased head circumference and body weight, 
response latencies, and differences in social interactions – suggest that there 
may be long-term consequences to early morphine exposure that we have yet to 
study. 
 
There has also been increasing concern about the potential effects that 
prolonged pain and sedation medication exposure may have on the developing 
brain, since the brain is undergoing a significant amount of growth and 
development in the infant. After an increase in the number of neurons and 
synapses in the infant brain have reached an appropriate stage, there begins a 
decline in the number of neurons and synapses (Davidson and Flick, 2013). 
Neurons are removed via controlled cell death called apoptosis. Data from rodent 
studies have shown that a potential effect of analgesics may be accelerated 
apoptosis in the brain (Yon, 2005; Davidson and Flick, 2013). The effects of 
analgesics on apoptosis depend on age, length, and dose of sedation exposure. 
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Prolonged continuous exposure and repeated exposure may also increase the 
frequency of adverse effects (Davidson and Flick, 2013). These changes in brain 
development may lead to permanent brain modifications, resulting in future long-
term consequences. 
 
Studies have begun to turn to longitudinal studies in order to get a better look at 
possible long-term consequences for infants with prolonged morphine exposure. 
Magnetic resonance imaging (MRI) provides a noninvasive way to study the 
structural and functional differences of the infant brain (Dean et al., 2013). While 
this is a great tool to use in hopes of being able to predict long-term 
consequences prior to clinical symptoms, MRI of infants and young children may 
prove difficult since a clear MRI for this kind of study requires a patient to remain 
still without the use of sedatives for a period of time – a task difficult for children. 
Due to the rapid brain growth and development of infants, MRI scans would 
prove most useful if they could be taken before sedation exposure, during the 
period of sedation exposure, and after prolonged sedation exposure. This would 
allow for a baseline view of what the structure and function of the brain was like 
before exposure to any pain or sedation medication (Dean et al., 2013). 
Longitudinal studies like this can be challenging since many parents will not MRI 
scan their children prior to a medical condition and may not re-scan children once 
they have been treated and left the hospital. Figure 10 shows what a typical MRI 
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scan would look like. To lessen the child’s movements and increase the quality of 
the image, MRI scans were performed during natural sleep (Dean et al., 2013). 
 
FIGURE 10: Representative anatomical image and derived brain maps. These images depict 
the typical quality of a child’s MRI scan. This scan in particular was acquired from a 21-month-old 
patient. Figure taken from Dean et al., 2013. 
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Many of the studies that have put a focus on determining possible short-term and 
long-term sequelae of prolonged sedation exposure have used preterm neonates 
as their population of study. This is because preterm babies (born less than 37 
weeks gestational age) often have many health issues requiring mechanical 
ventilation or surgical procedures, therefore leading to the necessary treatment 
with pain and sedation medications. A study performed on very preterm infants 
(born less than 30 weeks gestational age) showed that low-dose morphine 
exposure during care in the NICU was associated with altered cerebral structure, 
such as smaller brain volumes, and neurobehavioral issues (Steinhorn et al., 
2015). But after follow-up at ages 2 and 7 years old, it was found that these 
problems did not persist; morphine exposed infants showed no significant 
difference in behavior once they progressed into later childhood (Steinhorn et al., 
2015). But long-term effects may include a permanent alteration in sensory 
processing and future pain responses (Walker, 2009).  These effects include 
differences in heat and mechanical sensitivity such as decreased thermal 
sensitivity in areas near scars, possibly due to localized tissue injury (Walker, 
2009). 
 
Overall, infants are at high risk of possible short-term and long-term sequelae 
due to prolonged sedation exposure because their brains and immature nervous 
systems are at a particularly vulnerable stage of development. Preterm babies 
are at even higher risk since they often suffer from health issues and medical 
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conditions that may require long durations of mechanical ventilation or repeated 
surgical procedures, both resulting in pain and sedation management with the 
use of opioids and benzodiazepines. Infants with the longest or highest total dose 
of sedation exposure are also at risk. The frequency and severity of adverse 
effects are influences by the age at which the neonate is exposed stress and 
pain and to sedation medication, the amount of medication used, the length of 
exposure, and repeated exposure. 
 
  
 33 
DISCUSSION 
 
Data suggests that treatment with opioids and benzodiazepines can improve 
clinical outcomes by reducing pain and stress. We know that chronic untreated 
pain leads to adverse effects such as increased heart and respiratory rates, 
fluctuations in intracranial pressure, and increased stress hormone levels. These 
could lead to further complications such as IVH, PVL, or even death. So pain and 
sedation management is an important part of treatment in order to prevent these 
effects of undermanaged pain. But it needs to be taken into careful consideration 
that the sedation exposure may at some point become more detrimental than 
beneficial for the infant being treated. 
 
Since infants treated in the NICU and PICU do not have a uniform, standardized 
treatment plan, recommended guidelines are followed by physicians. But this can 
lead to variations in pain and sedation management, as well as different clinical 
outcomes. Large doses of opioids and benzodiazepines are being administered 
to infants for extended periods of time, leaving these neonates at risk of not only 
short-term but also long-term sequelae. The preterm infant population is 
particularly vulnerable, since their brains are still rapidly developing and there 
susceptible to neurological effects of the sedation medications (Anand et al., 
2010). Although undermanaged pain has its consequences, overestimating pain 
and administering excessive sedation medication may prove to be equally risky. 
Iatrogenic withdrawal is a common side effect of prolonged sedation, as well as 
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altered brain and nervous system development.  After extended opioid exposure, 
infants may develop tolerance and dependence and suffer from hyperalgesia and 
withdrawal. Figure 11 illustrates the diminished effects of opioid treatment.  
 
 
FIGURE 11: Clinical signs of diminished opioid analgesia. Decreased effectiveness of opioid 
analgesic may be due to tolerance, hyperalgesia, and/or worsening pain state. Figure taken from 
Anand et al., 2010. 
 
Opioid tolerance can be predicted by the total duration of opioid exposure. 
Tolerance rarely occurs after treatment of less than 72 hours (Anand et al, 2010). 
35% - 57% of patients in the PICU often develop opioid tolerance, resulting in a 
longer hospital stay or further health complications (Katz et al., 1994). A study 
found that opioid withdrawal occurred in 100% of patients under 2 years old who 
were treated with continuous fentanyl infusions for 9 or more days (Katz et al., 
1994). Signs of withdrawal include agitation, tremors, grimacing, sweating, 
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hypertensions, fever, vomiting, and diarrhea. In hopes of reducing tolerance and 
withdrawal symptoms, practical approaches could be used. Procedural changes 
such as interruption of the continuous infusion or sedative could be implemented 
(Anand et al., 2010). 
 
The introduction of the MRI has really allowed for doctors and researchers to 
study the function and structure of the brain in a noninvasive manner (Raschle, 
2012). Although it is difficult to scan an infant or child, seeing as they need to be 
motionless and not anaesthetized, the study of these scan could help us discover 
what, if any, consequences sedation exposure may have on the developing 
brain. Ideally, taking MRI scans before any sedation medication has been 
administered and then taking additional scans as the treatment is underway and 
after treatment has halted would be a great way to see the effects that the pain 
and sedation management have caused. Functional MRI could be used to 
monitor the effects that noxious stimuli may have on the developing brain 
(Hohmeister, 2010). 
 
Overall, prolonged sedation exposure has been shown to result in short-term 
effects that may or may not lead to long-term consequences. But infants are still 
at risk for long-term sequelae. Studies have begun to suggest that intelligence 
and brain volume as well as head circumference may be altered by extended 
sedation exposure (Ferguson, 2012). Guidelines and studies on medication, 
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dosage, and duration need to be further investigated in order for patients in the 
NICU and PICU to have the most effective treatment. Physicians have overcome 
the issue of undermanaging infant pain, but there is still the issue of 
overestimating pain and administering unnecessarily high dosages or extended 
durations of sedation medications. 
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FUTURE STUDIES 
 
This literature review suggests that infants, particularly preterm infants, are at 
high risk for developing short-term and long-term sequelae from prolonged 
sedation exposure. Future research is necessary to determine what the scope of 
long-term effects could be. This could include longitudinal studies that may 
involve the use of MRI scans and studies on the structure and function of the 
developing infant brain. Since there have been pilot studies indicating that 
prolonged sedation exposure may pose a long-term risk of intelligence deficits 
(de Graaf et al., 2011), more effective measures to quantify intelligence and 
behavior could be developed to help provide better understanding of possible 
neurological consequences.  
 
Studying MRI scans taken of infant brains could also shed new light on 
developing brains and alterations influenced by exposure to sedation medication. 
Future studies on brain resting state networks using MRI and functional MRI ( a 
sister technique to MRI that creates images of the brain based on metabolic 
function) may give us valuable new knowledge. 
 
Because there is currently no standardized guideline for pain and sedation 
management, there is great variability in treatment and drug administration. New 
assessment techniques could be used in accurately determining how much 
stress or pain an infant is feeling. Development and implementation of a 
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nationwide guideline for pain and sedation management in the NICU and PICU 
could be effective in treating patients and obtaining a higher frequency of positive 
clinical outcomes. By effectively treating patients, withdrawal symptoms could be 
lessened, weaning off of drugs could decrease in duration, and risk of short-term 
and long-term consequences could be diminished.  
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